122 related articles for article (PubMed ID: 1776410)
1. Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
Engler CB; Parving HH; Mathiesen ER; Larsen M; Lund-Andersen H
Acta Ophthalmol (Copenh); 1991 Oct; 69(5):581-5. PubMed ID: 1776410
[TBL] [Abstract][Full Text] [Related]
2. Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive type 1 (insulin-dependent) diabetic patients with background retinopathy.
Parving HH; Larsen M; Hommel E; Lund-Andersen H
Diabetologia; 1989 Jul; 32(7):440-4. PubMed ID: 2680698
[TBL] [Abstract][Full Text] [Related]
3. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
[TBL] [Abstract][Full Text] [Related]
4. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
5. The blood-ocular barrier in type I diabetes without diabetic retinopathy: permeability measurements using fluorophotometry.
Schalnus R; Ohrloff C
Ophthalmic Res; 1995; 27 Suppl 1():116-23. PubMed ID: 8577448
[TBL] [Abstract][Full Text] [Related]
6. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.
Engler C; Krogsaa B; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):442-6. PubMed ID: 1937077
[TBL] [Abstract][Full Text] [Related]
7. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
Chahal P; Fallon TJ; Jennings SJ; Chowienczyk PJ; Kohner EM
Diabetes Care; 1986; 9(2):134-9. PubMed ID: 3698779
[TBL] [Abstract][Full Text] [Related]
8. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
Larsen M; Hommel E; Parving HH; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):505-9. PubMed ID: 2265765
[TBL] [Abstract][Full Text] [Related]
9. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
Engler CB; Sander B; Larsen M; Koefoed P; Parving HH; Lund-Andersen H
Acta Ophthalmol (Copenh); 1994 Dec; 72(6):663-7. PubMed ID: 7747571
[TBL] [Abstract][Full Text] [Related]
10. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
Moldow B; Sander B; Larsen M; Engler C; Li B; Rosenberg T; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):881-9. PubMed ID: 9865617
[TBL] [Abstract][Full Text] [Related]
11. Mapping retinal fluorescein leakage with confocal scanning laser fluorometry of the human vitreous.
Lobo CL; Bernardes RC; Santos FJ; Cunha-Vaz JG
Arch Ophthalmol; 1999 May; 117(5):631-7. PubMed ID: 10326960
[TBL] [Abstract][Full Text] [Related]
12. Effect of sulindac on the permeability of the blood-retinal barrier in early diabetic retinopathy.
Cunha-Vaz JG; Mota CC; Leite EC; Abreu JR; Ruas MA
Arch Ophthalmol; 1985 Sep; 103(9):1307-11. PubMed ID: 2931063
[TBL] [Abstract][Full Text] [Related]
13. Long-term kinetic vitreous fluorophotometry in normal and diabetic subjects.
Knudsen LL; Olsen T; Nielsen-Kudsk F
Acta Ophthalmol (Copenh); 1992 Oct; 70(5):570-7. PubMed ID: 1471478
[TBL] [Abstract][Full Text] [Related]
14. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
[TBL] [Abstract][Full Text] [Related]
15. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative diabetic retinopathy.
Lobo CL; Bernardes RC; Figueira JP; de Abreu JR; Cunha-Vaz JG
Arch Ophthalmol; 2004 Feb; 122(2):211-7. PubMed ID: 14769598
[TBL] [Abstract][Full Text] [Related]
16. Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier.
Sander B; Larsen M; Moldow B; Lund-Andersen H
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):433-8. PubMed ID: 11157879
[TBL] [Abstract][Full Text] [Related]
17. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
[TBL] [Abstract][Full Text] [Related]
18. Oscillatory potentials and permeability of the blood-retinal barrier in noninsulin-dependent diabetic patients without retinopathy.
Yoshida A; Kojima M; Ogasawara H; Ishiko S
Ophthalmology; 1991 Aug; 98(8):1266-71. PubMed ID: 1923365
[TBL] [Abstract][Full Text] [Related]
19. Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and c-peptide levels.
Kernell A; Ludvigsson J; Finnström K
Acta Ophthalmol (Copenh); 1990 Aug; 68(4):415-20. PubMed ID: 2220357
[TBL] [Abstract][Full Text] [Related]
20. Ocular fluorometry methodological improvements and clinical studies--with special reference to the blood-retina barrier permeability to fluorescein and fluorescein glucuronide.
Larsen M
Acta Ophthalmol Suppl (1985); 1993; (211):1-52. PubMed ID: 8318868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
